276 related articles for article (PubMed ID: 21486217)
1. Targeting aldose reductase for the treatment of cancer.
Tammali R; Srivastava SK; Ramana KV
Curr Cancer Drug Targets; 2011 Jun; 11(5):560-71. PubMed ID: 21486217
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.
Ramana KV; Fadl AA; Tammali R; Reddy AB; Chopra AK; Srivastava SK
J Biol Chem; 2006 Nov; 281(44):33019-29. PubMed ID: 16956889
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice.
Yadav UC; Ramana KV; Aguilera-Aguirre L; Boldogh I; Boulares HA; Srivastava SK
PLoS One; 2009 Aug; 4(8):e6535. PubMed ID: 19657391
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.
Srivastava SK; Yadav UC; Reddy AB; Saxena A; Tammali R; Shoeb M; Ansari NH; Bhatnagar A; Petrash MJ; Srivastava S; Ramana KV
Chem Biol Interact; 2011 May; 191(1-3):330-8. PubMed ID: 21354119
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK
Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.
Yadav UC; Naura AS; Aguilera-Aguirre L; Ramana KV; Boldogh I; Sur S; Boulares HA; Srivastava SK
J Immunol; 2009 Oct; 183(7):4723-32. PubMed ID: 19752229
[TBL] [Abstract][Full Text] [Related]
7. Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.
Ramana KV; Srivastava SK
Cytokine; 2006 Nov; 36(3-4):115-22. PubMed ID: 17174561
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
[TBL] [Abstract][Full Text] [Related]
9. Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.
Huang L; He R; Luo W; Zhu YS; Li J; Tan T; Zhang X; Hu Z; Luo D
Recent Pat Anticancer Drug Discov; 2016; 11(2):184-96. PubMed ID: 26844556
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase and cancer metabolism: The master regulator in the limelight.
Syamprasad NP; Jain S; Rajdev B; Prasad N; Kallipalli R; Naidu VGM
Biochem Pharmacol; 2023 May; 211():115528. PubMed ID: 37011733
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells.
Pladzyk A; Reddy AB; Yadav UC; Tammali R; Ramana KV; Srivastava SK
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5395-403. PubMed ID: 17122129
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aldose reductase attenuates endotoxin signals in human non-pigmented ciliary epithelial cells.
Yadav UC; Srivastava SK; Ramana KV
Exp Eye Res; 2010 May; 90(5):555-63. PubMed ID: 20138035
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis.
Reddy AB; Srivastava SK; Ramana KV
Cytokine; 2009 Dec; 48(3):170-6. PubMed ID: 19660963
[TBL] [Abstract][Full Text] [Related]
14. Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways.
Zeng KW; Li J; Dong X; Wang YH; Ma ZZ; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2013 Nov; 273(1):159-71. PubMed ID: 24021941
[TBL] [Abstract][Full Text] [Related]
15. Torachrysone-8-O-β-d-glucoside mediates anti-inflammatory effects by blocking aldose reductase-catalyzed metabolism of lipid peroxidation products.
Zhao WL; Xu D; Wang JS
Biochem Pharmacol; 2023 Dec; 218():115931. PubMed ID: 37981172
[TBL] [Abstract][Full Text] [Related]
16. Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.
Maccari R; Ottanà R
J Med Chem; 2015 Mar; 58(5):2047-67. PubMed ID: 25375908
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase mediates the mitogenic signals of cytokines.
Ramana KV; Chandra D; Srivastava S; Bhatnagar A; Srivastava SK
Chem Biol Interact; 2003 Feb; 143-144():587-96. PubMed ID: 12604244
[TBL] [Abstract][Full Text] [Related]
18. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.
Liu J; Wen G; Cao D
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):246-53. PubMed ID: 19522700
[TBL] [Abstract][Full Text] [Related]
19. A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.
Pandey S; Srivastava SK; Ramana KV
Expert Opin Investig Drugs; 2012 Mar; 21(3):329-39. PubMed ID: 22283786
[TBL] [Abstract][Full Text] [Related]
20. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential.
Khayami R; Hashemi SR; Kerachian MA
J Cell Mol Med; 2020 Aug; 24(16):8890-8902. PubMed ID: 32633024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
